scispace - formally typeset
S

Sarah Sanowar

Researcher at Genentech

Publications -  15
Citations -  1155

Sarah Sanowar is an academic researcher from Genentech. The author has contributed to research in topics: Bacterial outer membrane & Periplasmic space. The author has an hindex of 11, co-authored 14 publications receiving 1075 citations. Previous affiliations of Sarah Sanowar include University of Washington & McGill University.

Papers
More filters
Journal ArticleDOI

Recognition of Antimicrobial Peptides by a Bacterial Sensor Kinase

TL;DR: It is shown that enzymatic activity of Salmonella typhimurium PhoQ is directly activated by antimicrobial peptides.
Journal ArticleDOI

A conserved structural motif mediates formation of the periplasmic rings in the type III secretion system

TL;DR: Using an integrated structural and experimental approach, ring models for the periplasmic domain of EscC are generated and placed in the context of the assembled T3SS, providing evidence for direct interaction between the outer membrane and inner membrane ring components and an unprecedented span of the outer membranes secretin.
Journal ArticleDOI

Antimicrobial Peptides Activate the Rcs Regulon through the Outer Membrane Lipoprotein RcsF

TL;DR: RcsFCDB activation in response to CAMP-induced membrane disorder is a result of a change in structure or availability of RcsF to the IM signaling constituents of the Rcs phosphorelay, which contributes to survival from polymyxin B exposure.
Journal ArticleDOI

Salmonella sensing of anti‐microbial mechanisms to promote survival within macrophages

TL;DR: Mechanisms by which Salmonella interacts with macrophages are discussed and the role of antimicrobial peptides and pH in PhoQ activation is focused on.
Journal ArticleDOI

Design and Pharmacokinetic Characterization of Novel Antibody Formats for Ocular Therapeutics.

TL;DR: It is demonstrated that protein molecular weight and Fc region do not play a critical role in ocular PK, as they do systemically, and the mathematical model supports the selection of the "ideal therapeutic" by predicting ocular and systemic PK of any antibody format for any dose regimen.